Early Detection and Impaired Quality of Life in COPD GOLD Stage 0: A Pilot Study

REFERENCES

• O'Donnell, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 2007; 14: 5B–32B
   PubMed Web of Science ®Google Scholar
• Editorial Board Respiratory Disease in Canada, Health Canada, http://www.statcan.ca/english/freepub/84F0209XIE/2003000/t001_en.pdf
   Google Scholar
• Murray C J, Lopez A D. Evidence-based health policy—lessons from the Global Burden of Disease Study. Science 1996; 274: 740–743
   PubMed Web of Science ®Google Scholar
• Lindstrom M, Jonsson E, Larsson K, Lundback B. Underdiagnosis of obstructive lung disease in northern Sweden. Int J Tuber Dis 2002; 6: 78–84
   Google Scholar
• Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson A C, Jonsson E, Larsson L G, Andersson S, Sandstrom T, Larsson K. Not 15 but 50% of smokers develop COPD?-Report from the Obstructive Lung Disease in Northern Sweden Studies. Resp Med 2003; 97: 115–122
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ichinose M, Inoue H, Shirato K, Hattori T, Takishima T. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 2003; 8: 504–508
   PubMed Web of Science ®Google Scholar
• Pauwels R A, Buist A S, Calverley P M, Jenkins C R. Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (Review) 2001; 163: 1256–1276
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis Management, and Prevention of COPD. Exec Summary Book. 2003, www.goldcopd.com
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis Management, and Prevention of COPD. 2006, www.goldcopd.com Guidelines November
   Google Scholar
• Newspaper Audience Data Bank (NADBank) Inc. The NADBank Study. Results 2004, www.nadbank.com
   Google Scholar
• Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321–1327
   PubMed Web of Science ®Google Scholar
• Crapo R O. Spirometry: Quality control and reproducibility criteria. Am Rev Respir Dis 1991; 143: 1212–1213
   PubMed Web of Science ®Google Scholar
• Swanney M P, Jensen R L, Crichton D A, Beckert L E, Cardno L A, Crapo R O. FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162: 917–919
   PubMed Web of Science ®Google Scholar
• Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airways obstruction in a general population: European Respiratory Society vs. American Thoracic Society definition. Chest 2000; 117: 339S–45S, (5 Suppl 2)
   PubMed Web of Science ®Google Scholar
• Rennard S, Decramer M, Calverley P M, Pride N B, Soriano J B, Vermeire P A, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799–80
   PubMed Web of Science ®Google Scholar
• Pena V S, Miravitlles M, Gabriel R, Jimenez-Ruiz C A, Villasante C, Masa J F, Viejo J L, Fernandez-Fau L. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981–989
   PubMed Web of Science ®Google Scholar
• Hasselgren M, Ame M, Lindahl A, Janson S, Lundback B. Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care 2001; 19: 54–57
   PubMed Web of Science ®Google Scholar
• Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey. 1988–1994. Arch Intern Med 2000; 160: 1683–1689
   PubMed Web of Science ®Google Scholar
• Bakke P S, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991; 46: 863–870
   PubMed Web of Science ®Google Scholar
• Vestbo J, Lange P. Can GOLD Stage 0 provide information on prognostic value in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 2002; 166: 329–332
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson A C, Ronmark E, Lundgren R, Larsson L G, Lundback B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005; 127: 1544–1552
   PubMed Web of Science ®Google Scholar
• Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R. Rengo F; SaRA Investigators Do GOLD stages of COPD severity really correspond to differences in health status?. Eur Respir J 2003; 22: 444–449
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson J A, Nilsson P M. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98, Aug 25
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Lange P, the Copenhagen City Heart Study Group. Association between chronic mucus hypersecretion with FEV1decline and COPD morbidity. Am J Respir Crit Care Med 1996; 153: 1530–1535
   PubMed Web of Science ®Google Scholar
• Krzyzanowski M, Camilli A E, Lebowitz M D. Relationships between pulmonary function and changes in chronic respiratory symptoms. Comparisons of Tucson and Cracow longitudinal studies. Chest 1990; 98: 62–70
   PubMed Web of Science ®Google Scholar
• Sherman C B, Xu X, Speizer F E, Ferris B G, Jr, Weiss S T, Dockery D W. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992; 146: 855–859
   PubMed Web of Science ®Google Scholar
• Hodder R. Complex obstructive pulmonary disease. Part II: Diagnosis, prevention and modern pharmacological management of COPD. Postgraduate Doctor Caribbean J 2004; 20: 6–11
   Google Scholar
• Jones P W, Bosh T K. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155(4)1283–1289, Apr
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society Am J Respir Crit Care Med 1995; S77–121
   Google Scholar